<DOC>
	<DOCNO>NCT01338649</DOCNO>
	<brief_summary>Study objectives determine efficacy , safety tolerability bright light treatment Parkinson 's Disease ( PD ) patient daytime sleepiness . Thirty PD patient enrol equally randomized bright light dim-red light treatment . Objective ( actigraphy ) subjective ( sleep logs/scales ) sleep measure collect baseline intervention phase study . The primary outcome measure change Epworth Sleepiness Scale ( ESS ) compare bright light treatment dim-red light treatment . Secondary outcome measure include Multiple Sleep Latency Test ( MSLT ) , global Pittsburgh Sleep Quality Index ( PSQI ) score , Parkinson 's Disease Sleep Scale ( PDSS ) score , actigraphy measure . A variety exploratory analyse examine effect bright light treatment fatigue , depression , quality life , cognition , motor disability . Hypothesis : Bright light exposure diminish daytime sleepiness improve night-time sleep PD patient daytime sleepiness .</brief_summary>
	<brief_title>Light Therapy Treatment Parkinson 's Disease Patients With Daytime Somnolence</brief_title>
	<detailed_description>See .</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Sleep Wake Disorders</mesh_term>
	<mesh_term>Parasomnias</mesh_term>
	<criteria>1 . Diagnosis idiopathic PD define United Kingdom Parkinson 's Disease Society Brain Bank Criteria 2 . Hoehn Yahr stage 2 4 `` '' state 3 . Excessive daytime sleepiness define Epworth Sleepiness Scale ( ESS ) score great equal 12 point 4 . Stable PD medication regimen least 4 week prior study screen 5 . Willing able give write informed consent 1 . Atypical parkinsonian syndrome 2 . Significant sleep disorder breathing ( define apneahypopnea index &gt; 15 events/hr sleep screen PSG ) 3 . Significant periodic limb movement disorder ( define PLM arousal index &gt; 10 events/hr sleep screen PSG ) REM sleep behavior disorder ( base presence clinical symptomatology well intermittent loss REM atonia screen PSG ) 4 . Cognitive impairment indicate minimental status examination ( MMSE ) score less 24 5 . Presence depression define Beck Depression Inventory ( BDI ) score &gt; 14 6 . Untreated hallucination psychosis ( druginduced spontaneous ) 7 . Use hypnosedative drug sleep stimulant daytime 8 . Use antidepressant unless patient stable dose least three month 9 . Visual abnormality may interfere light therapy , significant cataract , narrow angle glaucoma blindness 10 . Travel 2 time zone within 90 day prior study screen</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Parkinson 's disease</keyword>
	<keyword>Daytime somnolence</keyword>
	<keyword>Sleepiness</keyword>
	<keyword>Light therapy</keyword>
</DOC>